Latest issue of JNCI Monographs with multiple articles on cannabis policy and research

The December 2021 issue of JNCI Monographs has a series of papers stemming from a symposium last year organized by the National Cancer Institute exploring cannabis policy, public health and research. Here are just some of the great-looking articles in the issue:

"The National Cancer Institute and Cannabis and Cannabinoids Research"

"Cannabis Policy in the United States: Implications for Public Health"

"Nonmedical Cannabis Use: Patterns and Correlates of Use, Exposure, and Harm, and Cancer Risk"

"Cannabis and the Cancer Patient"

"Challenges for Clinical Cannabis and Cannabinoid Research in the United States"

Here is a short excerpt from the first of these article:

Recent survey evidence suggests that one-quarter of cancer patients have used cannabis, often to manage common cancer symptoms or treatment side effects, such as anorexia, nausea, and pain, and there is some evidence of ameliorative effects. A majority of US oncologists engage in discussions about cannabis use with patients, and although almost one-half of them recommend it clinically, few oncologists feel sufficiently informed to make recommendations to their patients regarding the use of cannabis. In general, studies that replicate the effects of cannabis and its constituents are needed as are improvements in research quality and surveillance capacity.